Masimo (NSDQ:MASI) said yesterday it is renewing a $1 million challenge made originally in 2013 that its SET pulse oximeter will outperform its device equivalent from competitor Nellcor, now owned by Medtronic (NYSE:MDT). If a hospital can prove in a head-to-head comparison that Masimo’s SET pulse oximeter is inferior to Nellcor’s device, Irvine, Calif.-based Masimo will pay […]